Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Radj Gervais Bartomeu Massuti Enric Carcereny Amelia Insa Ramon Palmero Romain Corre Rut Porta Maria Sanchez-Ronco Ana Drozdowskyj Isabel Bover Rosario Garcia-Campelo Miquel Taron Cristina Queralt Itziar de Aguirre Mariano Provencio Noemi Reguart Giuseppe Altavilla Vittorio Gebbia Filippo de Marinis Angel Artal Enriqueta Felip Julien Mazieres Dolores Isla Flavia Longo Alessandra Bearz Alain Vergnenegre Antonio Ramón Gómez-García Miguel Ángel Molina-Gutiérrez Teresa Morán-López Rafael Rosell Pilar Garrido |
| Publication date | March 2012 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |